FIELD: medicine, virology, pharmacy.
SUBSTANCE: invention proposes an agent for treatment and prophylaxis of infection caused by coronaviruses, in particular, for treatment of atypical pneumonia (SARS), and pharmaceutical composition of indicated designation based on thereof. Agent represents 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxybromoindole or 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxybromoindole monohydrate hydrochloride (arbidol) known early as an immunomodulator and preparation used against influenza viruses. Invention provides reducing accumulation of coronaviruses (on example with TOPS virus) in lung.
EFFECT: valuable medicinal properties of agent.
2 cl, 7 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
1-METHYL-2-PHENYLTHIOMETHYL-3-CARBETHOXY-4-DIMETHYLAMINOMETHYL-5- HYDROXY-6 -BROMOINDOLE MESYLATE ELICITING ANTIVIRAL ACTIVITY AND PHARMACEUTICAL COMPOSITION WITH ITS USAGE | 2004 |
|
RU2255086C1 |
PROPHYLACTIC AND CURATIVE AGENT FOR TREATING FLU VIRUS B | 1986 |
|
RU2008004C1 |
6-BROMO -5- HYDROXY-4- DIMETHYLAMINOMETHYL -1- METHYL -2-PHENYLTHIO- METHYLINDOLE -3- CARBOXYLIC ACID ETHYL ESTER HYDROCHLORIDE | 1974 |
|
RU2033156C1 |
PHARMACEUTICAL DRUG FOR TREATING ROTAVIRUS INFECTION CASES | 2004 |
|
RU2266742C1 |
ANTI-INFLAMMATORY AND ANTI-ALLERGIC MEDICATION AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2426540C1 |
DRUG POSSESSING INTERFERON-INDUCING AND IMMUNOMODULATING (IMMUNOSTIMULATING) ACTIVITY | 1987 |
|
RU2033157C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING ANTI-INFLAMMATORY, PARTICULARLY ANTIASTHMATIC ACTION, APPLICATIONS OF PHARMACEUTICAL COMPOSITION (VERSIONS) AND DRUG (VERSIONS) | 2008 |
|
RU2406498C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVES HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2552422C2 |
ARBIDOL-BASE MEDICINAL AGENT | 2003 |
|
RU2240784C1 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
Authors
Dates
2005-07-20—Published
2004-04-21—Filed